Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amino Alcohols. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109576238A reveals efficient transaminase route for chiral beta-amino alcohols. Enables cost reduction and high-purity supply for pharmaceutical intermediates manufacturing.
Patent CN1077565C reveals a robust Zr-Ni-Cu-Mo catalyst for amino alcohol amination, offering superior selectivity and supply chain stability for pharma intermediates.
Patent CN1075055C details a novel one-pot reduction of amino acids to amino alcohols using unactivated borohydrides, offering significant cost reduction and high chiral purity for pharmaceutical manufacturing.
Patent CN1678562A details a Rh-catalyzed method for high-purity amino alcohols, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Analysis of patent CN1282746C reveals a microbial route for high-purity beta-amino alcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN1842523A details a novel asymmetric hydrogenation process for enantiomerically pure beta-amino alcohols, offering significant cost reduction in API manufacturing.
Patent CN1224697C reveals a novel microbial process for high-purity aminoalcohols, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN101052604A details a catalytic de-enrichment method for chiral substrates, offering cost-effective recycling of unwanted isomers for pharmaceutical intermediate manufacturing.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Discover advanced chiral pyridoxal catalysts for asymmetric aldol reactions. Enable cost reduction in fine chemical manufacturing with scalable, metal-free synthesis routes.
Patent CN114591185B introduces a green iridium-catalyzed method for amino alcohol synthesis using ethylene glycol, offering high selectivity and supply chain advantages.
Patent CN116102464B details asymmetric hydrogenation for high-purity chiral amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Analysis of patent CN105130842B reveals a novel heterogeneous catalyst for chiral amino alcohol synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.